Peripheral mechanisms underlying the essential role of P2X7 receptors in the development of inflammatory hyperalgesia
- 1 October 2010
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 644 (1-3) , 55-60
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1αβ knockout miceBehavioural Brain Research, 2009
- ATP-gated P2X cation-channelsNeuropharmacology, 2009
- In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1β in the murine brainBrain, Behavior, and Immunity, 2008
- Discovery of P2X7 receptor‐selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain statesBritish Journal of Pharmacology, 2007
- The role of the purinergic P2X7 receptor in inflammationJournal of Inflammation, 2007
- A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the RatThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Effects of A‐317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administrationBritish Journal of Pharmacology, 2003
- Novel data point to a broader mechanism of action of oxidized ATP: the P2X7 receptor is not the only targetBritish Journal of Pharmacology, 2003
- Relief of inflammatory pain in rats by local use of the selective P2X7 ATP receptor inhibitor, oxidized ATPArthritis & Rheumatism, 2002
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983